Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 3/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | MAPT | P10636 | 3/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 4/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.37 |
| ▸ | TP53 | P04637 | 3/20 | 0.37 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 2/20 | 0.37 |
| ▸ | PKM | P14618 | 2/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | PPARG | P37231 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | GLA | P06280 | 1/20 | 0.35 |
| ▸ | ESR1 | P03372 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29420739 | 1.00 | TDP1 (0.44) | TDP1MEN1KMT2AMAPTSMN1; SMN2 | |
| SCHEMBL21829149 | 0.96 | TDP1 (0.41) | TDP1MEN1KMT2AMAPTSMN1; SMN2 | |
| SCHEMBL16172297 | 0.95 | TDP1 (0.40) | TDP1MEN1KMT2AMAPTSMN1; SMN2 | |
| SCHEMBL20492222 | 0.94 | TDP1 (0.43) | TDP1MEN1KMT2AMAPTSMN1; SMN2 | |
| SCHEMBL16903533 | 0.92 | TDP1 (0.38) | TDP1MEN1KMT2AMAPTSMN1; SMN2 | |
| SCHEMBL19445205 | 0.91 | TDP1 (0.37) | TDP1MEN1KMT2AMAPTSMN1; SMN2 | |
| SCHEMBL22493973 | 0.91 | TDP1 (0.37) | TDP1MEN1KMT2AMAPTSMN1; SMN2 | |
| SCHEMBL19442922 | 0.90 | TDP1 (0.36) | TDP1MEN1KMT2AMAPTSMN1; SMN2 | |
| SCHEMBL17985072 | 0.89 | TDP1 (0.43) | TDP1MEN1KMT2AMAPTSMN1; SMN2 | |
| SCHEMBL13827139 | 0.89 | TDP1 (0.46) | TDP1MEN1KMT2AMAPTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 332 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3312224-B1 | POLYAMIDE MOULDING COMPOSITION AND MULTI-LAYERED STRUCTURE MADE HEREFROM | EMS PATENT AG (CH) | 2018-12-26 | — | — | EP | claimed |
| JP-10045871-A | — | — | None | — | — | JP | disclosed |
| US-12570858-B2 | Curable composition, cured product, cured film, display panel, and method for producing cured film | TOKYO OHKA KOGYO CO., LTD. (JP) | 2026-03-10 | — | — | US | disclosed |
| EP-3888938-B1 | RUBBERY COMPOSITION AND METHOD FOR PRODUCING SAME | OSAKA GAS CO LTD (JP) | 2026-01-07 | — | — | EP | disclosed |
| US-12234352-B2 | Rubbery composition and method for producing the same | OSAKA GAS CO., LTD. (JP) | 2025-02-25 | — | — | US | disclosed |
| EP-4114825-B1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2024-11-20 | — | — | EP | disclosed |
| US-20240241439-A1 | PHOTOSENSITIVE RESIN COMPOSITION, CURED FILM AND BLACK MATRIX | Advanced Echem Materials Company Limited (TW) | 2024-07-18 | — | — | US | disclosed |
| US-20240241439-A1 | PHOTOSENSITIVE RESIN COMPOSITION, CURED FILM AND BLACK MATRIX | Advanced Echem Materials Company Limited (TW) | 2024-07-18 | — | — | US | disclosed |
| CN-118222209-A | Black optical film, cured film and application thereof | 杭州福斯特电子材料有限公司 | 2024-06-21 | — | — | CN | disclosed |
| CN-110007557-B | Curable composition, film, optical film, light-emitting display element panel, and light-emitting display device | 东京应化工业株式会社 | 2024-04-12 | — | — | CN | disclosed |
| EP-1788424-A1 | LIQUID CRYSTAL SEALING MATERIAL AND LIQUID CRYSTAL DISPLAY CELL USING SAME | Nippon Kayaku Kabushiki Kaisha (JP) | 2007-05-23 | — | — | EP | disclosed |
| EP-1778636-A1 | OXIME ESTER PHOTOINITIATORS | Ciba SC Holding AG (CH) | 2007-05-02 | — | — | EP | disclosed |
| US-20070020405-A1 | Sealant for liquid crystal and liquid-crystal display cell made with the same | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2007-01-25 | — | — | US | disclosed |
| US-20070020405-A1 | Sealant for liquid crystal and liquid-crystal display cell made with the same | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2007-01-25 | — | — | US | disclosed |
| US-20060241259-A1 | Oxime ester photoinitiators with heteroaromatic groups | CIBA CORPORATION | 2006-10-26 | — | — | US | disclosed |
| WO-2006037728-A1 | USE OF PYRIMIDO[5,4-G]PTERIDINES AS SHADING COMPONENT IN COLOR FILTER COLORANT COMPOSITIONS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2006-04-13 | — | — | WO | disclosed |
| WO-2006018405-A1 | OXIME ESTER PHOTOINITIATORS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2006-02-23 | — | — | WO | disclosed |
| EP-1567518-A2 | OXIME ESTER PHOTOINITIATORS WITH HETEROAROMATIC GROUPS | Ciba SC Holding AG (CH) | 2005-08-31 | — | — | EP | disclosed |
| WO-2004050653-A2 | OXIME ESTER PHOTOINITIATORS WITH HETEROAROMATIC GROUPS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2004-06-17 | — | — | WO | disclosed |
| JP-H1045871-A | EPOXY RESIN, EPOXY RESIN COMPOSITION AND CURED PRODUCT THEREFROM | NIPPON KAYAKU CO LTD | 1998-02-17 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12570858-B2 | Curable composition, cured product, cured film, display panel, and method for producing cured film | C5, CFL1, C9 | TDP1 3078/4885MEN1 79/4885KMT2A 3480/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.